Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Kendler

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 14, 2000
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronateR S Rittmaster, M Bolognese, M P Ettinger, et al.
Ultrasound in Medicine & Biology|December 4, 2001
Assessment of bone status using speed of sound at multiple anatomical sitesC F Njeh, I Saeed, M Grigorian, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 6, 2009
Population-based Canadian hip fracture rates with international comparisonsW D Leslie, S O'Donnell, C Lagacé, et al.
Calcified Tissue International|June 27, 2002
The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosisJ P Brown, D L Kendler, M R McClung, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 24, 2018
The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studiesD L Kendler, A Chines, M L Brandi, et al.
Aging (Milan, Italy)|February 1, 2002
Tolerability of risedronate in postmenopausal women intolerant of alendronateJ D Adachi, S Adami, P D Miller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 20, 2019
Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumabD L Kendler, H G Bone, F Massari, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 23, 2011
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled studyS L Silverman, A A Chines, D L Kendler, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 27, 2020
A scorecard for osteoporosis in Canada and seven Canadian provincesD L Kendler, J D Adachi, J P Brown, et al.
Archives of Osteoporosis|August 3, 2022
Trends in osteoporosis care patterns during the COVID-19 pandemic in Alberta, CanadaT Oliveira, J Brown, A G Juby, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Endocrinology and Metabolism|June 14, 2000
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronateR S Rittmaster, M Bolognese, M P Ettinger, et al.
Ultrasound in Medicine & Biology|December 4, 2001
Assessment of bone status using speed of sound at multiple anatomical sitesC F Njeh, I Saeed, M Grigorian, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 6, 2009
Population-based Canadian hip fracture rates with international comparisonsW D Leslie, S O'Donnell, C Lagacé, et al.
Calcified Tissue International|June 27, 2002
The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosisJ P Brown, D L Kendler, M R McClung, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 24, 2018
The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studiesD L Kendler, A Chines, M L Brandi, et al.
Aging (Milan, Italy)|February 1, 2002
Tolerability of risedronate in postmenopausal women intolerant of alendronateJ D Adachi, S Adami, P D Miller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 20, 2019
Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumabD L Kendler, H G Bone, F Massari, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 23, 2011
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled studyS L Silverman, A A Chines, D L Kendler, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 27, 2020
A scorecard for osteoporosis in Canada and seven Canadian provincesD L Kendler, J D Adachi, J P Brown, et al.
Archives of Osteoporosis|August 3, 2022
Trends in osteoporosis care patterns during the COVID-19 pandemic in Alberta, CanadaT Oliveira, J Brown, A G Juby, et al.
Pageof 5